Inhibition of angiogenesis and inflammation by an extract of red clover (Trifolium pratense L.)

Phytomedicine

Volumn 16, Issue 12, 2009, Pages 1083-1088

  Krenn, L ^a   Paper, D H ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b Anoxymer GmbH   (Germany)

Author keywords

Anti inflammatory effect; Antiangiogenic activity; CAM assay; HET CAM assay; Red clover; Trifolium pratense

Indexed keywords

ANGIOGENESIS INHIBITOR; BIOCHANIN A; DAIDZEIN; FORMONONETIN; GENISTEIN; RED CLOVER EXTRACT;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMOPROPHYLAXIS; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HEN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RED CLOVER; ZYGOTE;

ANGIOGENESIS INHIBITORS; ANIMALS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; GENISTEIN; INFLAMMATION; ISOFLAVONES; METHYLATION; PHYTOESTROGENS; PLANT EXTRACTS; TRIFOLIUM;

TRIFOLIUM PRATENSE;

EID: 70350580921     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.05.017     Document Type: Article

References (28)

1. Beck V., Unterrieder E., Krenn L., Kubelka W., and Jungbauer A. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J. Steroid Biochem. Mol. Biol. 84 (2003) 259-268
2. Beck V., Rohr U., and Jungbauer A. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy?. J. Steroid Biochem. Mol. Biol. 94 (2005) 499-518
3. Booth N.L., and Piersen C.E. Red Clover (Trifolium pratense). In: Coates P.M. (Ed). Encyclopedia of Dietary Supplements (2005), Marcel Dekker Inc., New York 587-602
4. Booth N., Overk C.R., Yao P., Totura S., Deng Y., Hedayat A.S., Bolton J.L., Pauli G.F., and Farnsworth N.R. Seasonal variation of Red Clover (Trifolium pratense L., Fabaceae) Isoflavones and Estrogenic Activity. J. Agric. Food. Chem. 54 (2006) 1277-1282
5. Bürgermeister J., Paper D.H., Vogl H., Linhardt R.J., and Franz G. LaPSvS1, a (1→3)-α-galactan sulfate and its effect on angiogenesis in vivo and in vitro. Carbohydr. Res. 337 (2002) 1459-1466
6. Carmeliet P. Angiogenesis in health and disease. Nature Med. 9 (2003) 653-660
7. Cornwell T., Cohick W., and Raskin I. Dietary phytoestrogens and health. Phytochemistry 65 (2004) 995-1016
8. Chedraui P., Hidalgo L., San Miguel G., Morocho N., and Ross S. Red clover extract (MF11RCE) supplementation and postmenopausal vaginal and sexual health. Int. J. Gynecol. Obstet. 95 (2006) 296-297
9. D'Arcy P.F., and Howard E.M. A new anti-inflammatory test, utilizing the chorioallantoic membrane of the chick embryo. Br. J. Pharmacol. Chemother. 29 (1967) 378-387
10. Farina H.G., Pomie M., Alonso D.F., and Gomez D.E. Antitumor and antiangiogenic activity of isoflavone genistein in mouse models of melanoma and breast cancer. Oncol. Rep. 16 (2006) 885-891
11. Geller S.E., and Studee L. Soy and red clover for mid-life and ageing. Climacteric 9 (2006) 245-263
12. Handayani R., Rice L., Cui Y., Medrano T.A., Samedi V.G., Baker H.V., Szabo N.J., and Shiverick K.T. Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells. J. Nutr. 136 (2006) 75-82
13. Huntley A.L., and Ernst E. Soy for the treatment of perimenopausal symptoms - a systematic review. Maturitas 53 (2004) 471-479
14. Imhof M., Gocan A., Reithmayr F., Lipovac M., Schimitzek C., Chedraui P., and Huber J. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas 55 (2006) 76-81
15. Joussen A., Rohrschneider K., Reichling J., Kirchhof B., and Kruse F. Treatment of corneal neovascularization with dietary isoflavonoids and flavonoids. Exp. Eye Res. 71 (2000) 483-487
16. Kiriakidis S., Hoegemeier O., Starcke S., Dombrowski F., Hahne J.C., Pepper M., Jha H.C., and Wernert N. Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay. Br. J. Nutr. 93 (2005) 317-323
17. Krenn L., Unterrieder I., and Ruprechter R. Quantification of isoflavones in red clover by HPLC. J. Chromatogr. B 777 (2002) 123-128
18. Marchesan M., Paper D.H., Hose S., and Franz G. Investigations of the anti-inflammatory activity of liquid extracts of Plantago lanceolata L. Phytother. Res. 12 (1998) S33-S34
19. Miura ., Vuan L., Sun B., Fuji H., Yoshida M., Wakame K., and Kosuna K.-I. Isoflavone aglycon produced by culture of soybean extracts with basidiomycetes and its anti-angiogenic activity. Biosci., Biotechnol. Biochem. 66 (2002) 2626-2631
20. Paper D.H., Vogl H., Franz G., and Hoffmann R. Macromol. Symp. 99 (1995) 219-225
21. Paper D.H. Natural products as angiogenesis inhibitors. Planta Med. 64 (1998) 686-695
22. Reichling J., Harkenthal M., Landvatter U., Saller R., and Erdinger L. Ätherische Öle im HET-CAM-Test. Dtsch. Apoth. Ztg. 41 (2000) 4688-4694
23. Setchell K.D.R., Brown N.M., Desai P., Zimmer-Nechemias L., Wolfe B.E., Brashear W.T., Kirschner A.S., Cassidy A., and Heubi J.E. Bioavailability of Pure Isoflavones in Healthy Humans and Analysis of Commercial Soy Isoflavone Supplements. J. Nutr. 131 4S (2001) 1362S-1375S
24. Su S.J., Yeh T.M., Chuang W.J., Ho C.L., Chang K.L., Cheng H.L., Liu H.S., Cheng H.L., Hsu P.Y., and Chow N.H. The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem. Pharmacol. 69 (2005) 307-318
25. Tempfer C.B., Bentz E.-K., Leodolter S., Tscherne G., Reuss F., Cross H.S., and Huber J.C. Phytoestrogens in clinical practice: a review of the literature. Fertil. Steril. 87 (2007) 1243-1249
26. Wang B., Zou Y., Li H., Yan H., Pan J.-S., Yuan Z.-L., Singh A.V., Franke A.A., Blackburn G.L., and Zhou J.R. Genistein inhibited retinal neovascularisation and expression of vascular endothelial growth factor and hypoxia inducible factor 1α in a mouse model of oxygen induced retinopathy. J. Ocul. Pharmacol. Ther. 21 (2005) 107-113
27. Whatmore J.L., Swann E., Barraja P., Newsome J.J., Bunderson M., Beall H.D., Tooke J.E., and Moody C.J. Comperative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents. Angiogenesis 5 (2002) 45-51
28. Zhou J., Gugger E., Tanaka T., Guo Y., Blackburn G., and Clinton S. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J. Nutr. 129 (1999) 1628-1635